We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

86 hedge funds and large institutions have $32.3M invested in Spectrum Pharmaceuticals Inc in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 20 increasing their positions, 25 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,271% more call options, than puts

Call options by funds: $480K | Put options by funds: $35K

15% less funds holding

Funds holding: 101 → 86 (-15)

20% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 25

42% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 31

65% less capital invested

Capital invested by funds: $92.5M → $32.3M (-$60.2M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
86
Holders Change
-15
Holders Change %
-14.85%
% of All Funds
1.45%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
18
Increased
20
Reduced
25
Closed
31
Calls
$480K
Puts
$35K
Net Calls
+$445K
Net Calls Change
+$97K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.7M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$762K
3
Citadel Advisors
Citadel Advisors
Florida
+$653K
4
E
Ergoteles
New York
+$392K
5
US Bancorp
US Bancorp
Minnesota
+$343K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$6.97M
2
State Street
State Street
Massachusetts
-$2.31M
3
PAM
Panagora Asset Management
Massachusetts
-$1.09M
4
Northern Trust
Northern Trust
Illinois
-$1.01M
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$874K
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
51
Cubist Systematic Strategies
Connecticut
$14K +$16.2K +18,343 New
AC
52
Armistice Capital
New York
$13.3K – – –
Creative Planning
53
Creative Planning
Kansas
$13K – – –
PCM
54
Pinz Capital Management
New York
$12K +$13.7K +15,600 New
ProShare Advisors
55
ProShare Advisors
Maryland
$11K -$29.5K -33,513 -70%
Man Group
56
Man Group
United Kingdom
$11K – – –
Wolverine Trading
57
Wolverine Trading
Illinois
$11K +$3.5K +3,969 +39%
RJFSA
58
Raymond James Financial Services Advisors
Florida
$10K – – –
TRCT
59
Tower Research Capital (TRC)
New York
$8K -$7.74K -8,780 -46%
PA
60
Parallel Advisors
California
$8K -$590 -670 -6%
MWM
61
Mission Wealth Management
California
$8K – – –
NFC
62
Northeast Financial Consultants
Connecticut
$8K – – –
ACM
63
Aquatic Capital Management
Illinois
$5K +$6.08K +6,900 New
TWM
64
Tradition Wealth Management
Minnesota
$4K – – –
Citigroup
65
Citigroup
New York
$3K -$9.36K -10,617 -72%
VCM
66
Versant Capital Management
Arizona
$3K – – –
KFI
67
Key Financial Inc
Pennsylvania
$2K – – –
SPIA
68
Steward Partners Investment Advisory
New York
$2K – – –
UBS Group
69
UBS Group
Switzerland
$2K – – –
Fidelity Investments
70
Fidelity Investments
Massachusetts
$2K +$283 +321 +11%
PVH
71
Psagot Value Holdings
Israel
$2K +$1.76K +2,000 New
FDCDDQ
72
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.25K – – –
New York State Common Retirement Fund
73
New York State Common Retirement Fund
New York
$1K -$96K -108,878 -99%
CAPTRUST Financial Advisors
74
CAPTRUST Financial Advisors
North Carolina
$1K – – –
FWM
75
Focused Wealth Management
New York
$1K – – –
1 2
3
4 5

SPPI Hedge Fund Activity: Q2 2022 in Review

86 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2022, worth a combined $32.3M — down 65% from $92.5M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of SPPI and 18 opened new positions — a net loss of 13 holders — while 25 trimmed existing stakes and 20 added.

The largest buyer was Millennium Management, adding an estimated $1.7M. The largest seller was BlackRock, cutting an estimated $6.97M.

  • 86 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2022, down from 101 in Q1 2022.
  • Funds reported $32.3M of Spectrum Pharmaceuticals Inc stock for Q2 2022, down 65% quarter-over-quarter.
  • 18 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2022 and 31 closed out, a net change of -13 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q2 2022 was Millennium Management, an estimated $1.7M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q2 2022 was BlackRock, an estimated $6.97M sold.

Based on aggregated 13F filings for Q2 2022.